Logo     Print Page  Close Window


SEC Filings


SC 13G
ANSON FUNDS MANAGEMENT LP filed this Form SC 13G on 06/01/2018
Entire Document
 
SC 13G

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO

RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(b)

 

 

Fibrocell Science, Inc.

(Name of Issuer)

Common Stock, $.001 par value

(Title of Class of Securities)

315721407

(CUSIP Number)

May 29, 2018

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☒ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)